The forecast for liver malignant neoplasms mortality in the US shows a gradual increase from 2024 to 2028, with rates rising from 9.0 to 9.6 deaths per hundred thousand persons. In 2023, the rate stood at 8.8, marking a year-on-year increase of approximately 2.3% in 2024. By analyzing trends, the compound annual growth rate (CAGR) from 2024 to 2028 indicates an average annual increase of about 1.6% in liver cancer mortality rates.
Future trends to watch for include demographic shifts such as aging populations, advancements in medical treatments, and lifestyle changes, which could influence liver cancer mortality rates. Monitoring these factors will be crucial for understanding potential deviations from current forecasts.
